beta-adrenergic blocker

Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.

Being a beta-adrenergic blocker, it is used to label the beta-adrenergic receptor for isolation.

Phenoxybenzamine use is safe in pregnancy, but beta-adrenergic blockers should be initiated only if needed because their use has been associated with intrauterine growth retardation.

Propanolol or beta-adrenergic blockers are often prescribed as well as insertion of a pacemaker to maintain proper heart rhythm.

Cardiovascular drugs: beta-adrenergic blockers, digitalis glycosides, quinidine, verapamil (oral)

Propafenone differs from the prototypical class Ic antiarrhythmic in that it has additional activity as a beta-adrenergic blocker which can cause bradycardia and bronchospasm.

The beneficial role of beta-adrenergic blockers in reducing the risk of sudden death and reinfarction in individuals with coronary artery disease and a previous myocardial infarction is well established.

If tachycardia develops or if blood pressure control is not optimal with alpha-adrenergic blockade, a beta-adrenergic blocker (e.g., metoprolol or propranolol) can be added but only after alpha-blockade.

More technically called beta-adrenergic blockers, the drugs actually block a class of chemical receptors called beta nerve receptors on the surface of cells in the sympathetic nervous system that help control the heart.

We now know that beta-adrenergic blocker therapy reduces the risk for sudden death and reinfarction in individuals with previous myocardial infarction and should be used in all patients with cardiac arrest and coronary artery disease unless there is a strong contradiction.